These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26801163)

  • 41. Chemoembolization of hepatocellular carcinoma--what to tell the skeptics: review and meta-analysis.
    Ramsey DE; Geschwind JF
    Tech Vasc Interv Radiol; 2002 Sep; 5(3):122-6. PubMed ID: 12524642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patients' global evaluation of analgesia and safety of injected parecoxib for postoperative pain: a quantitative systematic review.
    Kranke P; Morin AM; Roewer N; Eberhart LH
    Anesth Analg; 2004 Sep; 99(3):797-806. PubMed ID: 15333414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial.
    Lv N; Kong Y; Mu L; Pan T; Xie Q; Zhao M
    Eur Radiol; 2016 Oct; 26(10):3492-9. PubMed ID: 26801163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study.
    Zhou ZG; Chen JB; Qiu HB; Wang RJ; Chen JC; Xu L; Chen MS; Zhang YJ
    Oncotarget; 2016 May; 7(19):27938-45. PubMed ID: 27056892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect and Safety of Prophylactic Parecoxib for Pain Control of Transarterial Chemoembolization in Liver Cancer: A Single-Center, Parallel-Group, Randomized Trial.
    Lyu N; Kong Y; Li X; Guo N; Lai J; Li J; Zhao M
    J Am Coll Radiol; 2022 Jan; 19(1 Pt A):61-70. PubMed ID: 34736908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pain Management Using Perioperative Administration of Parecoxib for Total Hip Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Xiao K; Yu L; Xiao W; Peng H; Bian Y; Wu Z; Weng X
    Pain Physician; 2019 Nov; 22(6):575-582. PubMed ID: 31775404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma.
    Guo JG; Zhao LP; Rao YF; Gao YP; Guo XJ; Zhou TY; Feng ZY; Sun JH; Lu XY
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):510-516. PubMed ID: 30135046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parecoxib sodium reduces the need for opioids after tonsillectomy in children: a double-blind placebo-controlled randomized clinical trial.
    Li X; Zhou M; Xia Q; Li J
    Can J Anaesth; 2016 Mar; 63(3):268-74. PubMed ID: 26684457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Staging of hepatocellular carcinoma.
    Duseja A
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S74-9. PubMed ID: 25755615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of disease progression with anti-inflammatory therapy in patients with HCV-related cirrhosis: a Markov model.
    Ikeda K; Kawamura Y; Kobayashi M; Fukushima T; Sezaki H; Hosaka T; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Oncology; 2014; 86(5-6):295-302. PubMed ID: 24924385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC).
    Hayakawa K; Tanikake M; Kirishima T; Yoshinami N; Shintani H; Yamamoto E; Morimoto T
    Eur Radiol; 2014 May; 24(5):1105-11. PubMed ID: 24526284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of perioperative parecoxib on postoperative pain and local inflammation factors PGE2 and IL-6 for total knee arthroplasty: a randomized, double-blind, placebo-controlled study.
    Zhu Y; Wang S; Wu H; Wu Y
    Eur J Orthop Surg Traumatol; 2014 Apr; 24(3):395-401. PubMed ID: 23483320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea.
    Ikeda M; Arai Y; Park SJ; Takeuchi Y; Anai H; Kim JK; Inaba Y; Aramaki T; Kwon SH; Yamamoto S; Okusaka T; ;
    J Vasc Interv Radiol; 2013 Apr; 24(4):490-500. PubMed ID: 23466316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.
    Peng ZW; Zhang YJ; Chen MS; Xu L; Liang HH; Lin XJ; Guo RP; Zhang YQ; Lau WY
    J Clin Oncol; 2013 Feb; 31(4):426-32. PubMed ID: 23269991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver cancer: effects, safety, and cost-effectiveness of controlled-release oxycodone for pain control after TACE.
    Zhou B; Wang J; Yan Z; Shi P; Kan Z
    Radiology; 2012 Mar; 262(3):1014-21. PubMed ID: 22357901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model.
    Ikeda K; Kobayashi M; Kawamura Y; Imai N; Seko Y; Hirakawa M; Hosaka T; Sezaki H; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Liver Int; 2011 May; 31(5):692-9. PubMed ID: 21457441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of hepatocellular carcinoma: an update.
    Bruix J; Sherman M;
    Hepatology; 2011 Mar; 53(3):1020-2. PubMed ID: 21374666
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.